Milan - Delayed Quote EUR
Edwards Lifesciences Corporation (1EW.MI)
66.62
+0.57
+(0.86%)
At close: April 7 at 2:24:16 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
5,439,500
5,439,500
5,010,000
4,464,000
5,232,500
Cost of Revenue
1,117,500
1,117,500
978,400
723,700
1,248,900
Gross Profit
4,322,000
4,322,000
4,031,600
3,740,300
3,983,600
Operating Expense
2,841,900
2,841,900
2,545,400
2,201,200
2,396,800
Operating Income
1,480,100
1,480,100
1,486,200
1,539,100
1,586,800
Net Non Operating Interest Income Expense
100,500
100,500
49,600
16,300
-1,000
Other Income Expense
-32,500
-32,500
-163,400
-35,900
116,200
Pretax Income
1,548,100
1,548,100
1,372,400
1,519,500
1,702,000
Tax Provision
152,100
152,100
152,400
195,500
198,900
Net Income Common Stockholders
4,174,600
4,174,600
1,402,400
1,521,900
1,503,100
Diluted NI Available to Com Stockholders
4,174,600
4,174,600
1,402,400
1,521,900
1,503,100
Basic EPS
6.98
6.98
2.31
2.46
2.41
Diluted EPS
6.97
6.97
2.30
2.44
2.38
Basic Average Shares
597,700
597,700
606,700
619,000
623,300
Diluted Average Shares
599,300
599,300
609,400
624,200
631,200
Total Operating Income as Reported
1,378,700
1,378,700
1,308,900
1,498,400
1,690,300
Total Expenses
3,959,400
3,959,400
3,523,800
2,924,900
3,645,700
Net Income from Continuing & Discontinued Operation
4,174,600
4,174,600
1,402,400
1,521,900
1,503,100
Normalized Income
1,436,889.80
1,436,889.80
1,372,352
1,356,239.55
1,402,157.39
Interest Income
120,300
120,300
67,200
35,500
17,400
Interest Expense
19,800
19,800
17,600
19,200
18,400
Net Interest Income
100,500
100,500
49,600
16,300
-1,000
EBIT
1,567,900
1,567,900
1,390,000
1,538,700
1,720,400
EBITDA
1,723,100
1,723,100
1,534,900
1,678,300
1,855,200
Reconciled Cost of Revenue
1,117,500
1,117,500
978,400
723,700
1,248,900
Reconciled Depreciation
155,200
155,200
144,900
139,600
134,800
Net Income from Continuing Operation Net Minority Interest
1,400,900
1,400,900
1,223,000
1,324,000
1,503,100
Total Unusual Items Excluding Goodwill
-39,900
-39,900
-168,000
-37,000
114,300
Total Unusual Items
-39,900
-39,900
-168,000
-37,000
114,300
Normalized EBITDA
1,763,000
1,763,000
1,702,900
1,715,300
1,740,900
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-3,910.20
-3,910.20
-18,648
-4,760.45
13,357.39
12/31/2021 - 12/14/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade